First coronavirus vaccinations begin in the U.S.
Science writer and New York Times columnist Carl Zimmer joined "Red and Blue" to break down how the Pfizer vaccine works and what hurdles might come up in the vaccine rollout.
TechnologyLast
Science writer and New York Times columnist Carl Zimmer joined "Red and Blue" to break down how the Pfizer vaccine works and what hurdles might come up in the vaccine rollout.